Wheatgrass Product - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The wheatgrass products market size is expected to grow from USD 231.58 million in 2025 to USD 245.73 million in 2026 and is forecast to reach USD 330.56 million by 2031 at 6.11% CAGR over 2026-2031. This report is Segmented by Product Type (Juice, Powder, Pills), Nature (Organic, Conventional), Distribution Channel (Supermarkets and Hypermarkets, Convenience Stores, Specialty Stores, Online Retail Stores, Other Distribution Channels), and Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Units).

Global Wheatgrass Product Market Trends and Insights

Growing demand for natural detox and immunity supplements

In the aftermath of the pandemic, consumers have increasingly integrated immunity-boosting and detoxification practices into their daily wellness routines. This behavioral shift has driven a sustained demand for botanical supplements, which are now perceived as preventive health measures rather than reactive remedies. Among these, wheatgrass has gained attention due to its high chlorophyll content and antioxidant properties, which resonate strongly with detoxification narratives. However, it is important to highlight that the clinical evidence supporting these claims remains limited, primarily stemming from small-scale trials. In India, the nutraceuticals sector mirrors this global trend, experiencing significant growth as households frequently consume vitamins, minerals, and herbal supplements, often without consulting healthcare professionals. This shift from treatment-oriented to preventive consumption patterns is particularly evident in urban markets, where consumers are increasingly prioritizing proactive health management. The structural demand for such products is expected to stabilize over the medium term, as the process of habit formation and the establishment of repeat purchase cycles typically takes 2-4 years to solidify across various demographic groups.

Increasing prevalence of chronic illnesses

The global rise in chronic diseases positions wheatgrass as a nutrient-dense option, particularly for individuals managing diabetes, cardiovascular conditions, and obesity. For example, the World Health Organization (WHO) states that cardiovascular diseases (CVDs) account for over 42.5% of annual deaths in Europe in 2024, making them the leading cause of disability and premature death in the region. The USDA's 2024 guidelines for vegan diets emphasize the necessity of supplements such as vitamin B12, vitamin D, calcium, iron, and DHA/EPA. This is especially important for individuals on plant-based diets, commonly adopted by chronic disease patients, to meet their Dietary Reference Intakes. Iron requirements, in particular, are 1.8 times higher due to the lower bioavailability of non-heme iron. Wheatgrass, rich in vitamins A, C, E, and essential minerals, is increasingly marketed as a solution to address these nutritional gaps. However, its efficacy compared to targeted supplementation remains under-researched. While the long-term nature of chronic disease management ensures consistent demand, the market penetration of wheatgrass depends on clinical validation and endorsements from healthcare professionals, support that remains limited compared to established interventions like omega-3 or vitamin D.

Strong earthy taste limits repeat purchase

Wheatgrass's grassy and bitter flavor profile continues to act as a significant deterrent for first-time users, while also limiting repeat purchase rates, making sensory acceptance the primary obstacle to its mainstream adoption. To address this challenge, the industry has implemented various strategies, including flavor masking through encapsulation, blending wheatgrass with naturally sweeter ingredients such as pineapple or apple in juice formulations, and introducing gummy formats that completely eliminate the need to taste the product. Amazing Grass's upcoming launch of "Amazing Greens Mood Blend" in March 2024 highlights a dual approach of flavor innovation and functional positioning to overcome this barrier. Although consumer surveys consistently identify taste as the leading reason for discontinuation, the industry's continuous advancements in formulation are steadily reducing this gap and improving consumer acceptance.

Other drivers and restraints analyzed in the detailed report include:

• Surge in plant-based, vegan, and vegetarian diets favoring nutrient-rich superfoods
• Advancements in regenerative farming and processing technologies
• High production costs associated with organic cultivation and quality preservation

Segment Analysis

In 2025, powder products accounted for 77.62% of the market share, highlighting their adaptability in smoothies, shakes, and functional beverages. Their popularity is further supported by lower per-dose costs compared to encapsulated formats. However, pills, comprising tablets and capsules, are experiencing significant growth, expanding at a 7.18% CAGR through 2031. This growth, the fastest among product types, is driven by their convenience, precise dosing, and ability to eliminate taste barriers. Urban consumers, particularly those with busy schedules and individuals managing chronic conditions, find pills especially appealing. They value the consistent dosing pills offer over the flexibility of preparation. On the other hand, the juice segment, the smallest in the market, faces challenges such as a short shelf life and the need for cold-chain logistics. Nonetheless, there is niche demand in juice bars and wellness centers, where the fresh-pressed appeal commands premium pricing.

Encapsulation technology is advancing rapidly. Manufacturers are increasingly adopting enteric coatings to enhance bioavailability and reduce gastric discomfort, directly addressing past concerns about wheatgrass's digestive effects. At the same time, the broader dietary supplements market is shifting toward gummy and chewable formats. While powder's dominance is expected to continue through 2031, supported by established supply chains and simpler manufacturing processes, a convergence in growth rates between pills and powders by the end of the decade could indicate pills' successful mainstream adoption. Regulatory frameworks, such as Japan's Food with Function Claims system, which requires clinical evidence for health claims, favor standardized pill formats. This preference for variable-composition powders could accelerate the shift toward pills in Asian markets.

Complete Report Scope:

• By Product Type
  • Juice
  • Powder
  • Pills (Tablets and Capsules)
• By Nature
  • Organic
  • Conventional
• By Distribution Channel
  • Supermarkets and Hypermarkets
  • Convenience Stores
  • Specialty Stores
  • Online Retail Stores
  • Other Distribution Channels
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Rest of South America
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Sweden
    • Belgium
    • Poland
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Thailand
    • Singapore
    • Indonesia
    • South Korea
    • Australia
    • New Zealand
    • Rest of Asia-Pacific
  • Middle East and Africa
    • United Arab Emirates
    • South Africa
    • Saudi Arabia
    • Nigeria
    • Egypt
    • Morocco
    • Turkey
    • Rest of Middle East and Africa

Geography Analysis

North America held a leading 54.88% share of global revenues 2025, driven by high per-capita supplement spending, a well-developed retail infrastructure, and strong consumer awareness of superfoods. While Canada and Mexico contribute smaller shares, Mexico's expanding middle class and wellness trends indicate untapped potential. The FDA's regulation of dietary supplements under the 1994 DSHEA provides a more permissive regulatory environment compared to Europe. However, increasing scrutiny of heavy-metal contamination in herbal products is raising quality standards. Although the region's mature market status suggests slower growth, innovation in functional beverages and gummy formats could help maintain momentum.

Asia-Pacific is the fastest-growing region, with a projected 7.21% CAGR through 2031. This growth is primarily driven by India's USD 8 billion nutraceuticals market, which is expanding at an annual rate of 11%, and China's increasing health awareness. India's widespread micronutrient deficiencies and rising household supplement adoption create a significant market opportunity. Additionally, the FSSAI's 2022 Ayurveda Aahara regulations provide a clear framework for wheatgrass products as functional foods. Japan's functional food market, valued at USD 30-40 billion, offers strong potential. Its notification-based Food with Function Claims system, which has approved over 1,700 products, is more accessible than the stricter FOSHU pathway. Meanwhile, China's updated 2024 health-food filing rules maintain positive-ingredient lists, requiring specific approvals for wheatgrass. This creates both entry barriers and quality assurance. Although Australia and New Zealand contribute smaller shares, their strong preference for organic and clean-label products aligns well with wheatgrass positioning. However, the region's growth is challenged by price sensitivity, fragmented regulations, and competition from traditional herbal remedies like Ayurvedic and TCM formulations.

Europe, South America, and the Middle East and Africa collectively represent the remaining market share. Europe demonstrates strong demand, primarily due to micronutrient inadequacies. However, EFSA's stringent health-claim substantiation requirements under Directive 2002/46/EC pose compliance challenges. At the same time, these strict measures help differentiate approved products in competitive markets. Germany, the United Kingdom, and France lead consumption, with organic and vegan certifications being key purchase drivers. South America, still in its early stages, shows potential in Brazil and Argentina due to their agricultural capacity and growing wellness trends. However, infrastructure gaps and import tariffs hinder market growth. The Middle East and Africa are slowly emerging, with the UAE and South Africa leading adoption among affluent urban consumers. Nevertheless, underdeveloped regulatory frameworks and fragmented distribution networks remain obstacles. These regions collectively offer long-term opportunities, dependent on infrastructure investments and regulatory harmonization.

List of Companies Covered in this Report:

• NOW Foods
• Glanbia plc (Amazing Grass)
• Pines International Inc.
• Nestle S.A. (Garden of Life)
• Navitas Organics
• Naturya Limited
• Terrasoul Superfoods
• Living MaKa P.B.C.
• Baidyanath Group
• AquaBella Organic Solutions LLC
• Jivo Wellness Pvt Ltd
• Synergy Natural
• DynamicGreens Ltd.
• Kapiva
• Pure Planet Inc.
• Sunfood Superfoods
• Organic India Pvt Ltd
• Easy Pha-max
• Wanshida Wheat Industry
• Green Foods Corp.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support